Innovating to Improve Heart Disease Care and Outcomes - Stanford Medicine Children's Health
Why It Matters
Personalized virtual surgery enhances precision and outcomes for complex pediatric heart defects, reducing risk and healthcare costs while cementing Stanford’s role as a national leader in cardiac innovation.
Key Takeaways
- •Stanford creates personalized digital heart models for surgical planning.
- •Virtual surgeries reduce uncertainty for complex congenital heart procedures.
- •Only West Coast center developing custom engineering software for heart disease.
- •Technology enables tailored treatment plans, improving patient outcomes.
- •Program positions Stanford among few U.S. centers using such tools.
Summary
The video spotlights Stanford Medicine Children’s Health’s Betty Irene Moore Children’s Heart Center, which has pioneered a method to generate personalized digital replicas of patients’ hearts and blood vessels. These 3‑D models allow surgeons to rehearse procedures virtually before stepping into the operating room, tailoring interventions to each child’s unique anatomy.
By integrating engineering software with clinical expertise, Stanford creates patient‑specific virtual surgeries that reduce uncertainty in complex congenital cases. The center is among a handful of U.S. institutions employing such tools and the sole West Coast facility developing custom software for congenital heart disease, positioning it at the forefront of precision cardiac care.
A spokesperson notes, “We’re one of a small handful of centers nationwide using these tools and the only West Coast center developing customized engineering software specifically for congenital heart disease.” This capability enables clinicians to design optimal treatment plans, anticipate challenges, and improve surgical outcomes.
The technology promises to set a new standard for pediatric cardiac surgery, potentially lowering complication rates, shortening hospital stays, and attracting patients seeking cutting‑edge care, while reinforcing Stanford’s leadership in medical innovation.
Comments
Want to join the conversation?
Loading comments...